Utility of hemoglobin A1c for the identification of individuals with diabetes and prediabetes in a Chinese high risk population

References

• World Health Organization. The world health report: primary healthcare – now more than ever. Geneva: WHO, 2008.
   Google Scholar
• Gabbay KH, Hasty K, Breslow JL, Ellison RC, Bunn HF, Gallop PM. Glycosylated haemoglobin and long term blood glucose control in diabetes mellitus. J Clin Endocrinol Metab 1977;44:859–64.
   PubMed Web of Science ®Google Scholar
• International Expert Committee Report on the role of the A1C assay in the diagnosis of diabetes. Diab Care 2009; 32:1327–34.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diab Care 2010;33:S62–9.
   PubMedGoogle Scholar
• Waugh N, Scotland G, McNamee P, Gillett M, Brennan A, Goyder E, Williams R, John A. Screening for type 2 diabetes: literature review and economic modelling. Health Technol Assess 2007;11:1–125.
   Web of Science ®Google Scholar
• American Diabetes Association. Screening for type 2 diabetes (position statement). Diab Care 2004;27:S11–4.
   PubMed Web of Science ®Google Scholar
• Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393–403.
   PubMed Web of Science ®Google Scholar
• Engelgau MM, Geiss LS, Saaddine JB, Boyle JP, Benjamin SM, Gregg EW, Tierney EF, Rios-Burrows N, Mokdad AH, Ford ES, Imperatore G, Narayan KM. The evolving diabetes burden in the United States. Ann Intern Med 2004;140: 945–50.
   PubMed Web of Science ®Google Scholar
• Goodall I, Colman PG, Schneider HG, McLean M, Barker G. Desirable performance standards for A1c analysis – precision, accuracy and standardisation. Clin Chem Lab Med 2007;45:1083–97.
   PubMed Web of Science ®Google Scholar
• www.who.int/diabetes/publications/report-hba1c_2011.pdf
   Google Scholar
• American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diab Care 2004;27(Suppl. 1): S5–14.
   PubMedGoogle Scholar
• Lawrence JM, Bennett P, Young A, Robinson AM. Screening for diabetes in general practice: cross-sectional population study. BMJ 2001;323:548–51.
   PubMed Web of Science ®Google Scholar
• Nakagami T, and the DECODA Study Group. Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin. Diabetologia 2004;47:385–94.
   PubMed Web of Science ®Google Scholar
• DECODE Study Group, European Diabetes Epidemiology Group. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and non-cardiovascular diseases? Diab Care 2003;26:688–96.
   PubMed Web of Science ®Google Scholar
• Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med 2004:141;413–20.
   PubMed Web of Science ®Google Scholar
• Nuwin N, Shaw J, Zimmet P, Alberti KG. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diab Med 2002;19: 708–23.
   PubMedGoogle Scholar
• Williams DE, Cadwell BL, Cheng YJ, Cowie CC, Gregg EW, Geiss LS, Engelgau MM, Narayan KM, Imperatore G. Prevalence of impaired fasting glucose and its relationship with cardiovascular disease risk factors in US adolescents. Pediatrics 2005;116:1122–6.
   PubMed Web of Science ®Google Scholar
• Heldgaard PE, Olivarius Nde F, Hindsberger C, Henriksen JE. Impaired fasting glycaemia resembles impaired glucose tolerance with regard to cardiovascular risk factors: population-based, cross-sectional study of risk factors for cardiovascular disease. Diab Med 2004;21:363–70.
   PubMedGoogle Scholar
• Lim SC, Tai ES, Tan BY, Chew SK, Tan CE. Cardiovascular risk profile in individuals with borderline glycemia: the effect of the 1997 American Diabetes Association diagnostic criteria and the 1998 World Health Organization Provisional Report. Diab Care 2000;23:278–82.
   PubMed Web of Science ®Google Scholar
• Rohlfing CL, Rohlfing CL, Little RR, Wiedmeyer HM, England JD, Madsen R, Harris MI, Flegal KM, Eberhardt MS, Goldstein DE. Use of GHb (HbA1c) in screening for undiagnosed diabetes in the U.S. population. Diab Care 2000;23:187–91.
   PubMed Web of Science ®Google Scholar
• Engelgau M.M., Thompson TJ, Herman WH, Boyle JP, Aubert RE, Kenny SJ, Badran A, Sous ES, Ali MA. Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes: diagnostic criteria and performance revised. Diab Care 1997;20:785–91.
   PubMed Web of Science ®Google Scholar
• Bao Y, Ma X, Li H, Zhou M, Hu C, Wu H, Tang J, Hou X, Xiang K, Jia W. Glycated haemoglobin A1c for diagnosing diabetes in Chinese population: cross sectional epidemiological survey. BMJ 2010;340:c2249.
   PubMed Web of Science ®Google Scholar
• Ko GT, Chan JC, Yeung VT, Chow CC, Tsang LW, Li JK, So WY, Wai HP, Cockram CS. Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects. Diab Care 1998;21:1221–5.
   PubMedGoogle Scholar
• Ministry of Health, Labour and Welfare. National Diabetes Survey, 2002, www.health-net.or.jp/data/menu05/toukei/tonyo_h14.pdf [in Japanese].
   Google Scholar
• Nakagami T, Tominaga M, Nishimura R, Yoshiike N, Daimon M, Oizumi T, Tajima N. Is the measurement of glycated hemoglobin A1c alone an efficient screening test for undiagnosed diabetes? Japan National Diabetes Survey. Diab Res Clin Pract 2007;76:251–6.
   PubMedGoogle Scholar
• Miyazaki M, Kubo M, Kiyohara Y, Okubo K, Nakamura H, Fujisawa K, Hata Y, Tokunaga S, Iida M, Nose Y, Ishibashi T; and the Hisayama study. Comparison of diagnostic methods for diabetes mellitus based on prevalence of retinopathy in a Japanese population: the Hisayama Study. Diabetologia 2004;47:1411–5.
   PubMed Web of Science ®Google Scholar
• Buell C, Kermah D, Davidson MB. Utility of A1C for diabetes screening in the 1999–2004 NHANES population. Diab Care 2007;30:2233–5.
   PubMedGoogle Scholar
• Ko GT, Chan JC, Tsang LW, Cockram CS. Combined use of fasting plasma glucose and HbA1c predicts the progression to diabetes in Chinese subjects. Diab Care 2000;23: 1770–3.
   PubMedGoogle Scholar